Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.

Who would not like to completely cleanse and detox their vital organs? What if we told you that starting your day with a ...

Your liver plays crucial roles in filtering toxins, converting food into fuel, strengthening immunity and keeping blood sugar ...

Raising taxes on alcohol and tobacco is a viable financing model to combat lifestyle diseases, as the high cost of treatment continues to burden low-income individuals suffering from non-communicable ...

Semaglutide, used for diabetes and obesity, may reduce alcohol cravings in adults with alcohol use disorder, offering a potential solution to a major treatment gap.

Raichur: Shilpa Medicare Limited, recently announced that its Investigational New Drug (IND), Nor-Ursodeoxycholic Acid ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

The trials identified no serious adverse effects, and patients tolerated a daily dosage of 1500 mg for 24 weeks.

The Liver Doc, Dr. Cyriac Abby Philips, shares an evidence-based workout plan to manage and treat NAFLD effectively.

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

Shilpa Medicare announces the approval of its IND - Nor Ursodeoxycholic Acid Tablets 500 mg, by the Subject Expert Committee of CDSCO. The Committee has further recommended grant of marketing ...